Validation of the Ankylosing Spondylitis Disease Activity Score with a Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study - ACR Meeting Abstracts

Por um escritor misterioso
Last updated 06 novembro 2024
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Background/Purpose: According to international recommendations, the Ankylosing Spondylitis Disease Activity Score (ASDAS) is the preferred score for assessing disease activity in axial spondyloarthritis (axSpA) [1]. However, routine determination of C-reactive protein (CRP) to calculate ASDAS values takes hours to days. This limits the use of ASDAS in clinical routine and clinical trials and hinders the […]
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
FRI0126 The Ankylosing Spondylitis Disease Activity Score (ASDAS
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Achievement of Remission Endpoints with Secukinumab Over 3 Years
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
POS1104 BIMEKIZUMAB MAINTAINED STRINGENT CLINICAL RESPONSES
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Performance of the Ankylosing Spondylitis Disease Activity Score
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) Performance of the Ankylosing Spondylitis Disease Activity
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Gerd BURMESTER, Professor
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) ASAS-EULAR recommendations for the management of axial
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) The Effect of Golimumab Therapy on Disease Activity and
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) POS0241 VALIDATION OF THE ANKYLOSING SPONDYLITIS DISEASE
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
High disease activity according to the Ankylosing Spondylitis
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Gerd BURMESTER, Professor
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
J. Brandt-Juergens's research works
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
PDF) ASAS40 and ASDAS clinical responses in the ABILITY-1 clinical
Validation of the Ankylosing Spondylitis Disease Activity Score with a  Quick Quantitative Creactiveprotein Assay (ASDAS-qCRP) in Patients with  Axial Spondyloarthritis (axSpA): Aprospective, National, Multicenter Study  - ACR Meeting Abstracts
IJMS, Free Full-Text

© 2014-2024 blog.nationbloom.com. All rights reserved.